[go: up one dir, main page]

JPS6485092A - Production of protein - Google Patents

Production of protein

Info

Publication number
JPS6485092A
JPS6485092A JP62240513A JP24051387A JPS6485092A JP S6485092 A JPS6485092 A JP S6485092A JP 62240513 A JP62240513 A JP 62240513A JP 24051387 A JP24051387 A JP 24051387A JP S6485092 A JPS6485092 A JP S6485092A
Authority
JP
Japan
Prior art keywords
protein
useful protein
vaccinia virus
dna coding
hiv tat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62240513A
Other languages
English (en)
Inventor
Asato Kojima
Takeshi Kurata
Atsushi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
National Institutes of Health NIH
Original Assignee
Nippon Zeon Co Ltd
National Institutes of Health NIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd, National Institutes of Health NIH filed Critical Nippon Zeon Co Ltd
Priority to JP62240513A priority Critical patent/JPS6485092A/ja
Publication of JPS6485092A publication Critical patent/JPS6485092A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16311Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP62240513A 1987-09-25 1987-09-25 Production of protein Pending JPS6485092A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62240513A JPS6485092A (en) 1987-09-25 1987-09-25 Production of protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62240513A JPS6485092A (en) 1987-09-25 1987-09-25 Production of protein

Publications (1)

Publication Number Publication Date
JPS6485092A true JPS6485092A (en) 1989-03-30

Family

ID=17060637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62240513A Pending JPS6485092A (en) 1987-09-25 1987-09-25 Production of protein

Country Status (1)

Country Link
JP (1) JPS6485092A (ja)

Similar Documents

Publication Publication Date Title
NO874750L (no) Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
NO912642L (no) Fremstilling av proteiner ved bruk av homolog rekombinasjon.
JPS6479124A (en) Factor viii analogue, manufacture and medicine
EP0752874A4 (en) A STRENGTHENED VIRUS-TRANSFERED DNA TRANSFER
ES8708251A1 (es) Un metodo de producir insulina humana
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
DE3853422D1 (de) HIV-3-Retrovirus und seine Verwendung.
AU554080B2 (en) Production of viral antisens
ATE231729T1 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
GB8914968D0 (en) Production of virus and purification of viral envelope proteins for vaccine use
ES8608581A1 (es) Un metodo para la construccion de un gen sintetico para pro-teina objetivo viral
HUP0101081A2 (hu) Tápközeg és eljárás vírustenyésztésre és szaporításra
KR900702045A (ko) 천연 hiv gp 160의 제조방법
JPS6485092A (en) Production of protein
EP0112012A3 (en) Recombinant DNA molecules
CN104178494A (zh) 一种人白介素2的制备工艺及其应用
NZ507942A (en) Viral chimeras comprised of CAEV and HIV-1 genetic elements
AU4590889A (en) Protease, reverse transcriptase and endonuclease of petrovirus, and method for producing these enzymes
EP1309342A4 (en) PRODUCTION OF CHIMERIC HUMAN PAPILLOMAVIRUS
FR2261779A1 (en) Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
JPS6485072A (en) Recombinant vaccinia virus
JPS6485094A (en) Novel physiologically active polypeptide
DK125786A (da) Peptider og fremstilling deraf
SU1540269A1 (ru) Штамм гибридных культивируемых клеток животного mus musculus, используемый для получения моноклональных антител к поверхностному гликопротеину вирусов комплекса клещевого энцефалита
FI881294L (fi) FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi